Neuregulin1 fine-tunes pre-, post-, and perisynaptic neuromuscular junction development.

Area of Science:

• Neuroscience
• Developmental Biology

Background:

• Neuromuscular junction (NMJ) development involves complex communication between nerve terminals, muscle, and Schwann cells.
• Neuregulin1 (NRG1) is a known anterograde signal for acetylcholine receptor (AChR) transcription and clustering in vitro.
• The in vivo role of NRG1 in NMJ development remains largely uncharacterized.

Purpose of the Study:

• To investigate the in vivo effects of Neuregulin1 (NRG1) signaling on neuromuscular junction (NMJ) development.
• To quantify the impact of NRG1 on AChR cluster size and density, pre- and postsynaptic apposition, and perisynaptic Schwann cell alignment.

Main Methods:

• Utilized a chicken embryo model for in ovo studies of NMJ development.
• Employed in ovo electroporation for early-stage manipulation.
• Administered a soluble neuregulin antagonist throughout developmental stages to block NRG1 signaling.
• Quantitatively assessed AChR cluster characteristics, synaptic apposition, and Schwann cell alignment.

Main Results:

• Soluble NRG1 regulates AChR cluster density and size at early developmental stages, preceding nerve-AChR contact.
• Following nerve contact, NRG1 significantly impacts presynaptic specialization.
• NRG1 plays a crucial role in the alignment of perisynaptic Schwann cells at the NMJ endplates.

Conclusions:

• NRG1 is not essential for overall NMJ development but is critical for fine-tuning its structure.
• NRG1 influences pre-, post-, and perisynaptic components of the NMJ.
• These findings elucidate the specific roles of NRG1 in the intricate process of NMJ maturation.